Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| GH Research PLC(GHRS) | 10,763,288 | 13,263,288 | +2,500,000 | $151.33M | $356.52M | 41.19% | +$205.19M |
| Cullinan Therapeutics, Inc.(CGEM) | 8,963,500 | 8,963,500 | 0 | $127.37M | $163.23M | 18.86% | +$35.85M |
| Stoke Therapeutics, Inc.(STOK) | 4,763,673 | 4,038,404 | -725,269 | $155.11M | $132.14M | 15.27% | -$22.97M |
| Agios Pharmaceuticals, Inc.(AGIO) | 2,611,568 | 3,408,937 | +797,369 | $88.35M | $126.51M | 14.62% | +$38.16M |
| C4 THERAPEUTICS INC | 6,998,902 | 7,326,691 | +327,789 | $18.41M | $34.22M | 3.95% | +$15.81M |
| KORRO BIO INC | 1,538,296 | 1,538,296 | 0 | $17.41M | $20.27M | 2.34% | +$2.86M |
| TSCAN THERAPEUTICS INC | 8,019,148 | 8,019,148 | 0 | $8.10M | $7.86M | 0.91% | -$239.8K |
| PRECISION BIOSCIENCES INC | 985,113 | 950,466 | -34,647 | $5.42M | $7.47M | 0.86% | +$2.05M |
| NEUPHORIA THERAPEUTICS INC | 875,328 | 875,328 | 0 | $3.56M | $3.83M | 0.44% | +$262.6K |
| PASSAGE BIO INC | 623,704 | 673,759 | +50,055 | $4.90M | $3.29M | 0.38% | -$1.61M |
| CG Oncology, Inc.(CGON) | 31,591 | 31,391 | -200 | $2.14M | $2.23M | 0.26% | +$92.3K |
| PLIANT THERAPEUTICS INC | 0 | 1,798,070 | +1,798,070 | $0 | $2.05M | 0.24% | +$2.05M |
| ENTRADA THERAPEUTICS INC | 211,689 | 178,606 | -33,083 | $2.67M | $1.31M | 0.15% | -$1.36M |
| VYNE THERAPEUTICS INC | 1,628,700 | 1,628,700 | 0 | $973.1K | $1.06M | 0.12% | +$86.6K |
| PROQR THRAPEUTICS N V SHS EURO | 68,486 | 521,413 | +452,927 | $110.9K | $969.8K | 0.11% | +$858.9K |
| TRAWS PHARMA INC | 15,078 | 559,470 | +544,392 | $27.6K | $471.8K | 0.05% | +$444.2K |
| FOGHORN THERAPEUTICS INC | 0 | 61,588 | +61,588 | $0 | $300.5K | 0.03% | +$300.5K |
| Denali Therapeutics Inc.(DNLI) | 1,880,303 | 11,658 | -1,868,645 | $36.10M | $299.8K | 0.03% | -$35.80M |
| Xencor, Inc.(XNCR) | 536,398 | 18,194 | -518,204 | $6.47M | $292.9K | 0.03% | -$6.18M |
| ABSCI CORPORATION | 21,245 | 21,245 | 0 | $63.7K | $246.2K | 0.03% | +$182.5K |
| WEREWOLF THERAPEUTICS INC | 657,786 | 657,786 | 0 | $547.7K | $236.7K | 0.03% | -$310.9K |
| Immatics N.V.(IMTX) | 216,973 | 23,236 | -193,737 | $2.14M | $235.4K | 0.03% | -$1.90M |
| AVALO THERAPEUTICS INC | 0 | 10,100 | +10,100 | $0 | $186.6K | 0.02% | +$186.6K |
| BOLT BIOTHERAPEUTICS INC | 30,800 | 30,800 | 0 | $124.4K | $118.6K | 0.01% | -$5.9K |
| Nuvation Bio Inc.(NUVB) | 0 | 16,029 | +16,029 | $0 | $91.0K | 0.01% | +$91.0K |
| EUPRAXIA PHARMACEUTICALS INC | 0 | 10,000 | +10,000 | $0 | $66.1K | 0.01% | +$66.1K |
| INHIBIKASE THERAPEUTICS INC | 0 | 20,000 | +20,000 | $0 | $40.6K | 0.00% | +$40.6K |
| DESIGN THERAPEUTICS INC | 119,516 | 0 | -119,516 | $1.27M | $0 | — | -$1.27M |
| IBIO INC | 68,076 | 0 | -68,076 | $129.3K | $0 | — | -$129.3K |